Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Necrosis
MeSH D009336 - necrosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010335:
Pathologic processes
0 Companies
0 Drugs
Success rate
D009336:
Necrosis
4 Companies
1 Drug
$
Success rate
D003790:
Dental pulp necrosis
0 Companies
0 Drugs
Success rate
D005218:
Fat necrosis
0 Companies
0 Drugs
Success rate
D005734:
Gangrene
8 Companies
1 Drug
$
Success rate
D007238:
Infarction
0 Companies
0 Drugs
Success rate
D010020:
Osteonecrosis
0 Companies
0 Drugs
Success rate
D053836:
Necrotic dna degradation
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
20
%
1/5
Phase 3
50
%
1/2
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Phentolamine
Ocuphire Pharma
Phentolamine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use